Procter & Gamble Health enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY27Jun 2026FY26Jun 2025FY25Jun 2024FY24Jun 2023FY23 and earlierAlpha Plus
8,962————
FY23 and earlierEvery year the company has filed comes with Alpha Plus.
———239435
———−239−435
———538751
Reference items — trailing FY values
1,4333643391,1511,230
46699.690.3306324
44293.684.9279297
———228236
———207194
———206193
———21.742.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

PGHL₹5,399.00

Procter & Gamble Health Limited

· Pharma & Health
₹ CrorePeersSANOFICONRSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹8,962 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY24
30/06/2023
FY25
30/06/2024
FY26
30/06/2025
FY27
30/06/2026
Current/LTM
TTM · last close
Market Capitalization————8,962.3
- Cash, Equiv & ST Investments435.1238.5———
Net Debt (memo)-435.1-238.5———
Total Capital750.9538.2———
Reference Items — Trailing FY Values
Sales1,229.61,151.3338.7363.71,432.9
EBITDA324.0306.090.399.6465.9
EBIT296.6278.684.993.6441.8
Operating Cash Flow236.0228.3———
Free Cash Flow193.5206.6———
FCFF (free cash flow to the firm)193.3206.4———
Capital Expenditure42.521.7———
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY27 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.